Goldman Sachs’s Tevogen Inc. Warrant TVGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.59K Hold
105,800
﹤0.01% 6408
2025
Q4
$3.7K Hold
105,800
﹤0.01% 6390
2025
Q3
$5.87K Hold
105,800
﹤0.01% 6268
2025
Q2
$7.39K Hold
105,800
﹤0.01% 6012
2025
Q1
$5.7K Hold
105,800
﹤0.01% 5985
2024
Q4
$5.71K Hold
105,800
﹤0.01% 5948
2024
Q3
$1.36K Hold
105,800
﹤0.01% 5772
2024
Q2
$1.62K Buy
+105,800
New +$4.97K ﹤0.01% 5605
2024
Q1
Sell
-108,182
Closed -$4.33K 5933
2023
Q4
$4.33K Hold
108,182
﹤0.01% 5534
2023
Q3
$5.41K Hold
108,182
﹤0.01% 5441
2023
Q2
$4.47K Hold
108,182
﹤0.01% 5637
2023
Q1
$8.65K Hold
108,182
﹤0.01% 5751
2022
Q4
$335 Hold
108,182
﹤0.01% 5933
2022
Q3
$13K Hold
108,182
﹤0.01% 6004
2022
Q2
$17K Hold
108,182
﹤0.01% 6203
2022
Q1
$29K Buy
+108,182
New +$40.2K ﹤0.01% 6360

Other funds holding TVGNW

Goldman Sachs's TVGNW Position: Q1 2026 in Review

Goldman Sachs held its Tevogen Inc. Warrant (TVGNW) position steady in Q1 2026 at 105,800 shares worth $3.59K. The position accounts for ﹤0.01% of the portfolio, ranked #6408.

Goldman Sachs first reported a position in TVGNW in Q1 2022 and has held it in 16 quarters since. The position peaked at $29K in Q1 2022. 33 funds tracked by Wall St. Rank hold TVGNW as of Q1 2026.

  • Goldman Sachs held 105,800 shares of Tevogen Inc. Warrant worth $3.59K as of Q1 2026.
  • Goldman Sachs left its Tevogen Inc. Warrant share count unchanged in Q1 2026.
  • Tevogen Inc. Warrant made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #6408 holding.
  • Goldman Sachs first reported a position in Tevogen Inc. Warrant in Q1 2022 and has held it in 16 quarters since.
  • Goldman Sachs's Tevogen Inc. Warrant position peaked at $29K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held Tevogen Inc. Warrant as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.